Autoantigen diversity in the opsoclonus-myoclonus syndrome

被引:98
作者
Bataller, L
Rosenfeld, MR
Graus, F
Vilchez, JJ
Cheung, NKV
Dalmau, J
机构
[1] Hosp Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR USA
[5] Univ Barcelona, Hosp Clin, Dept Neurol, Barcelona, Spain
[6] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Barcelona, Spain
[7] Univ Hosp La Fe, Dept Neurol, Valencia, Spain
[8] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
关键词
D O I
10.1002/ana.10462
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite circumstantial evidence that opsoclonus-myoclonus (OM) is often immune mediated, no specific autoantigen has been identified. Using sera of 21 patients with several types of OM (idiopathic, associated to small cell lung cancer, and associated to neuroblastoma), we probed a brainstem cDNA library to isolate target neuronal antigens. Thirty-seven clones coding for 25 proteins were isolated, with two groups of autoantigens emerging: (1) proteins of the postsynaptic density, among them the adenomatous polyposis coli, and (2) proteins with expression or function restricted to neurons, including RNA or DNA-binding proteins and zinc-finger proteins. Usually, each patient's serum recognized a different autoantigen, except for adenomatous polyposis coli that was recognized by sera of two patients with idiopathic OM and two control patients with nystagmus, diplopia, and paraneoplastic brainstem dysfunction. Overall, in the indicated types of OM, (1) we found frequent and heterogeneous immunity to neuronal autoantigens without a single specific antibody marker of OM, (2) the occasional detection of antibodies to known onconeuronal antigens (ie, Hu proteins) probably is related to cancer-induced immunity rather than to OM, and (3) the postsynaptic density is a frequent source of novel autoantigens, with several proteins of this complex targeted by antibodies of OM patients.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 40 条
  • [21] LEIGH RJ, 1999, NEUROLOGY EYE MOVEME, P451
  • [22] ANTI-RI - AN ANTIBODY ASSOCIATED WITH PARANEOPLASTIC OPSOCLONUS AND BREAST-CANCER
    LUQUE, FA
    FURNEAUX, HM
    FERZIGER, R
    ROSENBLUM, MK
    WRAY, SH
    SCHOLD, SC
    GLANTZ, MJ
    JAECKLE, KA
    BIRAN, H
    LESSER, M
    PAULSEN, WA
    RIVER, ME
    POSNER, JB
    [J]. ANNALS OF NEUROLOGY, 1991, 29 (03) : 241 - 251
  • [23] All kinesin superfamily protein, KIF, genes in mouse and human
    Miki, H
    Setou, M
    Kaneshiro, K
    Hirokawa, N
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7004 - 7011
  • [24] Mok H, 2002, J NEUROSCI, V22, P5253
  • [25] New paths in human cancer serology
    Old, LJ
    Chen, YT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) : 1163 - 1167
  • [26] PARANEOPLASTIC CEREBELLAR DEGENERATION .1. A CLINICAL ANALYSIS OF 55-ANTI-YO ANTIBODY-POSITIVE PATIENTS
    PETERSON, K
    ROSENBLUM, MK
    KOTANIDES, H
    POSNER, JB
    [J]. NEUROLOGY, 1992, 42 (10) : 1931 - 1937
  • [27] THE NEUROBIOLOGY OF THE OPSOCLONUS-MYOCLONUS SYNDROME
    PRANZATELLI, MR
    [J]. CLINICAL NEUROPHARMACOLOGY, 1992, 15 (03) : 186 - 228
  • [28] The immunopharmacology of the opsoclonus-myoclonus syndrome
    Pranzatelli, MR
    [J]. CLINICAL NEUROPHARMACOLOGY, 1996, 19 (01) : 1 - 47
  • [29] The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders
    Rees, JH
    Hain, SF
    Johnson, MR
    Hughes, RAC
    Costa, DC
    Ell, PJ
    Keir, G
    Rudge, P
    [J]. BRAIN, 2001, 124 : 2223 - 2231
  • [30] OMNIPAUSE NEURONS IN 2 CASES OF OPSOCLONUS ASSOCIATED WITH OAT-CELL CARCINOMA OF THE LUNG
    RIDLEY, A
    KENNARD, C
    SCHOLTZ, CL
    BUTTNERENNEVER, JA
    SUMMERS, B
    TURNBULL, A
    [J]. BRAIN, 1987, 110 : 1699 - 1709